0.3102  -0.03 (-8.76%)		09-11 16:00
Open: 0.3371 High: 0.3401 Volume: 1,038,115		Pre. Close: 0.34 Low: 0.3058 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	0.7	1-year :	0.92
Resists	First :	0.6	Second :	0.79
Pivot price	0.38
Supports	First :	0.3	Second :	0.25
MAs	MA(5) :	0.33	MA(20) :	0.4
	MA(100) :	1.44	MA(250) :	4.47
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	3.3	D(3) :	3.3
RSI	RSI(14): 26.7
52-week	High :	14.8	Low :	0.3

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VNRX ] has closed above bottom band by 14.8%. Bollinger Bands are 76.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.34 - 0.34	0.34 - 0.34
Low:	0.3 - 0.3	0.3 - 0.3
Close:	0.31 - 0.31	0.31 - 0.31

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Fri, 11 Sep 2026
VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan

Thu, 10 Sep 2026
Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus

Thu, 10 Sep 2026
VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus

Wed, 09 Sep 2026
Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan

Tue, 08 Sep 2026
VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan

Thu, 27 Aug 2026
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.